-
Dupixent Lawsuits Being Filed for Patients: Medical Information and Legal Allegations
These Dupixent Cases Involving T-cell Lymphoma Cancer Are Against Regeneron Pharmaceuticals and Sanofi-Aventis We are currently investigating possible Dupixent lawsuits for patients who were diagnosed with a relatively rare cancer, T-cell lymphoma, after they…
-
Dupixent Drug Injury Lawsuits For Patients Diagnosed With CTCL Cancer
Cutaneous T-cell Lymphoma (CTCL) Cancer Includes Mycosis Fungoides And Sézary Syndrome (Posted by Tom Lamb at Drug Injury Watch) A growing body of medical evidence showing an association between Dupixent and cutaneous T-cell lymphoma (CTCL) has given…
-
More Evidence For Increased Risk of NAION With Ozempic or Mounjaro in Diabetes Patients
NAION is Likely Associated With Other Semaglutide or Tirzepatide GLP-1RA Drugs Used for Weight Loss (Posted by Tom Lamb at Drug Injury Watch) A new medical article published August 11, 2025, online by JAMA Network…
-
Current FDA Safety Investigation: NAION With Mounjaro, Zepbound, and Other GLP-1 RAs
Evaluating Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Possible Risk of NAION Side Effects (Posted by Tom Lamb at Drug Injury Watch) The FDA has been investigating "potential signals" of non-arteritic anterior ischemic optic neuropathy (NAION)…
-
Ozempic Vision Loss Lawsuits Have Been Filed by Patients Against Novo Nordisk
We List Some of the Legal Liability Allegations Regarding Drug Company Actions and Failures (Posted by Tom Lamb at Drug Injury Watch) During the past several weeks, Ozempic vision loss lawsuits have been filed by…